Diet & Nutrition News and Research

Latest Diet & Nutrition News and Research

Early antibiotic exposure can trigger long term susceptibility to asthma

Early exposure to antibiotics can trigger long term susceptibility to asthma, according to new research from Monash University.

15 Jul 2024

Study: Seven out of ten Spanish households regularly waste food

Seven out of ten Spanish households regularly waste food, according to a recent study by the Institute of Environmental Science and Technology at the Universitat Autònoma de Barcelona (ICTA-UAB).

15 Jul 2024

Drastic caloric restriction by athletes diminishes performance and compromises the immune system

Drastically cutting back on caloric intake to lose weight ahead of competition is commonplace among athletes.

15 Jul 2024

Long-term, 30-year CVD risk may help inform therapy for stage 1 hypertension

A comparison of two risk prediction tools used to calculate an individual's risk of developing cardiovascular disease (CVD) suggests that the long-term, 30-year risk should be considered in addition to the short-term, 10-year risk to help inform when to begin medication therapy for stage 1 hypertension, or high blood pressure, according to new research published today in Hypertension, an American Heart Association journal.

15 Jul 2024

Global childhood immunization coverage: Stalled progress and growing gaps

Global childhood immunization coverage stalled in 2023, leaving 2.7 million additional children un- and under-vaccinated compared to pre-pandemic levels in 2019, according to data published today by the World Health Organization (WHO) and UNICEF.

15 Jul 2024

Alcohol use significantly associated with mental illness symptoms in college women

The association between lifestyle factors and mental illness (MI) in college-going women.

15 Jul 2024

Study links improved dietary fat quality to reduced cardiovascular and diabetes risk

The impact of dietary fat quality on lipid metabolites and its association with reduced cardiometabolic disease risk.

15 Jul 2024

Twincretin drug Tirzepatide shows unmatched efficacy in weight loss and diabetes management

Tirzepatide, a novel twincretin drug, significantly improves weight loss and glycemic control in obese and type 2 diabetes patients, outperforming traditional treatments in clinical trials.

15 Jul 2024

40% of US cancer cases linked to lifestyle choices

Nearly 40% of cancer cases and 44% of cancer deaths in 2019 were due to modifiable risk factors, with cigarette smoking as the leading cause. This study highlights the potential to significantly reduce cancer burden through lifestyle changes.

14 Jul 2024

Study finds dried fruit consumption lowers type 2 diabetes risk

Recent research shows that higher dried fruit intake is linked to a reduced risk of type 2 diabetes, highlighting potential health benefits despite its sugar content.

14 Jul 2024

Do probiotics really benefit healthy people?

Recent research in Advances In Nutrition reviews the benefits of probiotics for healthy individuals, highlighting evidence gaps and the need for further study to support preventive recommendations.

14 Jul 2024

Lifestyle changes can greatly reduce heart disease risk in people with high genetic risk

Study highlights the significant impact of genetic risk and lifestyle on early- and late-onset cardiovascular diseases, showing that lifestyle improvements can notably reduce CVD risk, especially in high genetic risk individuals.

14 Jul 2024

Simple measures can help address malnutrition in elderly care

As many as half of all patients admitted to hospital and other healthcare facilities are malnourished. This has serious consequences for the individual in terms of unnecessary suffering, poorer quality of life and mortality.

12 Jul 2024

Nicotine absorption is much lower from second-hand vaping than from second-hand smoking

Children exposed to vaping indoors absorb less than one seventh the amount of nicotine as children who are exposed to indoor smoking, but more than those exposed to neither, according to a new study led by UCL researchers.

11 Jul 2024

Study: 40% of cancer cases in the U.S. attributable to modifiable risk factors

A new study led by researchers at the American Cancer Society (ACS) finds four in 10 cancer cases and about one-half of all cancer deaths in adults 30 years old and older in the United States (or 713,340 cancer cases and 262,120 cancer deaths in 2019) could be attributed to modifiable risk factors, including cigarette smoking, excess body weight, alcohol consumption, physical inactivity, diet, and infections.

11 Jul 2024

Lipidomics reveals health benefits of switching to plant-based fats

Switching from a diet high in saturated animal fats to one rich in plant-based unsaturated fats affects the fat composition in the blood, which in turn influences long-term disease risk.

11 Jul 2024

Archaeal, fungal, viral, as well as bacterial, functional makers for autism spectrum disorder in children

Researchers investigated the associations between multikingdom gut microbiome components and functional markers with autism spectrum disorder through metagenomic sequencing of children's fecal samples.

11 Jul 2024

Existing drug shows promise for treating common liver disease

The University of Barcelona has led a study that suggests using the drug known as pemafibrate to treat liver disease associated with metabolic disorders, the most common liver pathology in the world, which affects one in four people. The drug has long been marketed in Japan for another use: improving blood lipid levels in patients with hyperlipidaemia, a common condition in diabetics. Now, however, it could help address this serious liver disease, which still has no specific treatment.

11 Jul 2024

Gut bacteria-metabolized equol shows promise in cancer prevention

Researchers reviewed how soy isoflavones are metabolized by gut bacteria into equol, exploring its role in cancer prevention and treatment. They examined the molecular mechanisms and gut microbiota involved to understand equol's anti-tumor effects.

11 Jul 2024

Four years non-diabetic status after impaired glucose tolerance diagnosis cuts cardiovascular risks

Maintaining non-diabetic status for at least four years after impaired glucose tolerance diagnosis significantly lowers the risk of cardiovascular complications and mortality.

10 Jul 2024

Diet & Nutrition News and Research

Latest Diet & Nutrition News and Research

Early antibiotic exposure can trigger long term susceptibility to asthma

Study: Seven out of ten Spanish households regularly waste food

Drastic caloric restriction by athletes diminishes performance and compromises the immune system

Long-term, 30-year CVD risk may help inform therapy for stage 1 hypertension

Global childhood immunization coverage: Stalled progress and growing gaps

Alcohol use significantly associated with mental illness symptoms in college women

Study links improved dietary fat quality to reduced cardiovascular and diabetes risk

Twincretin drug Tirzepatide shows unmatched efficacy in weight loss and diabetes management

40% of US cancer cases linked to lifestyle choices

Study finds dried fruit consumption lowers type 2 diabetes risk

Do probiotics really benefit healthy people?

Lifestyle changes can greatly reduce heart disease risk in people with high genetic risk

Simple measures can help address malnutrition in elderly care

Nicotine absorption is much lower from second-hand vaping than from second-hand smoking

Study: 40% of cancer cases in the U.S. attributable to modifiable risk factors

Lipidomics reveals health benefits of switching to plant-based fats

Archaeal, fungal, viral, as well as bacterial, functional makers for autism spectrum disorder in children

Existing drug shows promise for treating common liver disease

Gut bacteria-metabolized equol shows promise in cancer prevention

Four years non-diabetic status after impaired glucose tolerance diagnosis cuts cardiovascular risks

News Medical 2025: Healthcare Shifts That Mattered Most eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Diet & Nutrition News and Research

Latest Diet & Nutrition News and Research

News Medical 2025: Healthcare Shifts That Mattered Most eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in